Clinical Trials Logo

Binge Drinking clinical trials

View clinical trials related to Binge Drinking.

Filter by:

NCT ID: NCT03288896 Completed - Alcohol Drinking Clinical Trials

Alerta Alcohol. Web-based Computer-tailored Intervention for Binge-drinking Prevention in Spanish Adolescents

Start date: November 1, 2016
Phase: N/A
Study type: Interventional

This study consists in the the design, implementation, and evaluation of the first web-based computer tailored intervention program aimed at the prevention of binge drinking in Spanish adolescents (Alerta Alcohol). A Cluster Randomized Controlled Trial is conducted to test the effectiveness of Alerta Alcohol in students aged 16 to 18 years across 16 high schools from Andalusia (southern Spain), which are randomized either to the experimental or the control condition (EC and CC).

NCT ID: NCT03169244 Completed - Alcohol Abuse Clinical Trials

Buproprion for Binge Drinking

Start date: September 4, 2017
Phase: Phase 2
Study type: Interventional

The present proposal is an innovative and translational clinical trial derived from exciting preclinical findings to test the hypothesis that treatment with the melanocortin activator bupropion can reduce binge drinking in humans. Furthermore, pilot data on moderating effects of coexisting nicotine use on the efficacy of bupropion for binge drinking population will be obtained. Evidence for an efficacy signal with good tolerability with this FDA approved medication would form the foundation to conduct a well-powered Phase II b trial. The development of an effective pharmacotherapy for binge drinking would be a significant clinical advance. .

NCT ID: NCT03062189 Completed - Binge Drinking Clinical Trials

Binge Drinking Among Youngs is a Risk Factor for Alcohol Use Disorders

Start date: January 2015
Phase: N/A
Study type: Observational

The purpose of this study was to assess drinking habits and patterns of alcohol consumption, smoking habits, use of illicit drugs and the prevalence of binge drinking and alcohol use disorders among Italian young students. Furthermore to investigate the correlation between binge drinking and alcohol use disorders.

NCT ID: NCT02842073 Completed - Binge Drinking Clinical Trials

An Open Label Trial of Bupropion and Naltrexone for Binge Drinking

Start date: November 1, 2016
Phase: Phase 2
Study type: Interventional

This is an open-label Phase IIa pilot study of the tolerability and effects on binge drinking of bupropion and naltrexone for binge drinkers.

NCT ID: NCT02794311 Completed - Binge Drinking Clinical Trials

Risk Factors Associated With Binge Drinking Behaviors Among College Students

AlcoolPredict
Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.

NCT ID: NCT02568904 Completed - Binge Drinking Clinical Trials

Alcohol and Innate Immunity

Start date: December 2016
Phase:
Study type: Observational

Alcohol leads to a leaky gut and translocation of bacterial products. This may lead to inflammation and immune dysfunction as well as the typical hangover symptoms.

NCT ID: NCT02336204 Completed - Binge Drinking Clinical Trials

Alcohol Consumption Relation With Nutritional Knowledge and Body Weight

Start date: September 2011
Phase: N/A
Study type: Observational

The increase of overweight and obesity in young Italian people, nowadays showed by several epidemiological data, has been related to the misuse of alcohol and to a lack in nutritional knowledge. Thus the aim of our study was to investigate if different nutritional knowledge from could affect body composition and drinking habits of a cohort of local young people. 104 healthy subjects (56 males and 54 females) were recruited using oral advertisements among the students of 18-19 years-old belonging to the Istituto Agrario and the Istituto alberghiero Raineri-Marcora of Piacenza. The subjects were asked to complete a questionnaire on alcohol consumption and another one related to nutritional knowledge. Then anthropometric data were measured: height, weight, waist and hips circumferences, waist-hips ratio and skinfolds were evaluated for each subject and body fat mass was calculated.

NCT ID: NCT02330419 Completed - HIV Clinical Trials

Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM

Say When
Start date: April 2015
Phase: Phase 2
Study type: Interventional

This is a double-blind, placebo-controlled trial of 120 binge-drinking MSM to 12 weeks of naltrexone 50mg, to be taken in anticipation of heavy drinking. Ethnically and racially diverse participants will be recruited using Respondent Driven Sampling as well as active field recruitment. MSM will be seen weekly for alcohol-metabolite urine testing, study drug dispensing, and brief counseling for alcohol use. Safety assessments and behavioral surveys will be completed monthly.

NCT ID: NCT02064998 Completed - Binge Drinking Clinical Trials

Two Consecutive Randomized Controlled Trials Using Mobile Phone Applications for Risky Alcohol Use

Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of three mobile phone applications, Promillekoll, PartyPlanner and TeleCoach among university student union members with problematic drinking. Two trials are conducted, one a three-armed randomized controlled study, and the second a two-armed randomized control study. Outcomes are measured in terms of changes in problematic alcohol use at follow up 6,12 and 18 weeks after baseline data gathering. Both the Promillekoll and PartyPlanner apps feature real time registration of alcohol consumption and give feedback of estimated blood alcohol concentration levels. PartyPlanner also allows for planning an alcohol consumption event in advance and for later comparison of the plan with actual consumption. Study 1 compares these two apps with a control group. In Study 2, participants reporting alcohol consumption above the weekly recommended level are redirected to randomized assignment to an in-depth app, TeleCoach, which offers different exercises for reducing alcohol use. After 6 weeks the controls are offered the TeleCoach intervention for 6 weeks, and the first intervention group loses app access. In both studies, followup occurs 6, 12 and 18 weeks after baseline registration. Hypotheses: Study 1: 1. The groups receiving the Promillekoll and PartyPlanner interventions will reduce their alcohol use to a larger extent than the control group at follow-up compared to the baseline level. 2. The planning function in PartyPlanner will be associated with an increased decrease in alcohol consumption compared to only real-time use for Promillekoll. Study 2: The proportion of participants with risky use above recommended levels will decline faster in the group that receives the intervention first, in comparison to controls.

NCT ID: NCT02045108 Completed - Binge Drinking Clinical Trials

Cognitive Retraining and Brain Stimulation for Alcohol Use

Start date: January 2014
Phase: N/A
Study type: Interventional

The overarching goal of this study is to determine whether combined cognitive training and Transcranial Direct Current Stimulation (tDCS) reduces drinking in high-risk drinkers. To this end, specific study purposes are: 1) replicate previous findings that cognitive retraining reduces drinking levels, 2) test whether cognitive retraining can be enhanced with tDCS, and 3) investigate the neural changes that result from cognitive retraining and tDCS. We hypothesize that those participants who receive alcohol avoidance cognitive training will have greater reductions in drinking. In turn, those participants who receive a higher level of applied tDCS during alcohol avoidance response training will have better avoidance learning, as well as, a larger reduction in drinking behavior. Finally, those participants receiving a higher level of applied tDCS will have more neuronal response associated with alcohol avoidance during the brain imaging session.